Undiagnosed clotting disorders are quite common.
Normal clotting studies in patients with recurrent thrombosis often remain a diagnostic mystery. In 1993 Dahlback and colleagues 1 described a pre viously unrecognised resistance to the anticoagulant response of Activated Protein C. Activated Protein C resistance is particularly common in young patients presenting with recurrent thrombosis. There is often a positive family history, and leg veins appear particularly predisposed to clotting in this disorder. 1 We describe a case of acute proptosis, due to cavernous sinus thrombosis, in a patient with Activated Protein C resistance.
CASE REPORT
A 32-year-old Caucasian man had a 10 year history of an undiagnosed thrombophilic state. The rest of the family were screened for APC resistance, and were all normal (ratio >4). The clotting cascade. Note the negative feedback loop: Thrombomodulin (TM) activates Protein C (PC), which is converted to Activated Protein C (APC). With Protein S (PS), APC inactivates factor Va and factor VIlla . TF, tissue factor; vWF, von Willebrand factor; Vi, inactivated factor V; VIlli, inactivated factor VIII. 
CONCLUSION
We describe the case of a young man with recurrent thrombosis, presenting with acute proptosis due to cavernous sinus thrombosis, who was subsequently found to have Activated Protein C resistance. This is an interesting, recently described mechanism which is proving common in young patients with hitherto undiagnosed thrombophilic states. We believe this is the first report of a patient with clotting in the deep venous system of the brain in association with Activated Protein C resistance. A degree of aware ness and vigilance for this newly described clotting disorder may yield a diagnosis in the young patient with thrombosis in the eye or orbit.
